No abstract available
Publication types
-
Clinical Trial, Phase II
-
Letter
-
Multicenter Study
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Carcinoma, Non-Small-Cell Lung / drug therapy*
-
Carcinoma, Non-Small-Cell Lung / genetics*
-
Carcinoma, Non-Small-Cell Lung / pathology
-
Carcinoma, Non-Small-Cell Lung / secondary
-
ErbB Receptors / genetics*
-
Erlotinib Hydrochloride / therapeutic use*
-
Humans
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / genetics*
-
Lung Neoplasms / pathology
-
Mutation*
-
Neoplasm Metastasis
-
Neoplasm Staging
-
Portugal
-
Protein Kinase Inhibitors / therapeutic use*
Substances
-
Antineoplastic Agents
-
Protein Kinase Inhibitors
-
Erlotinib Hydrochloride
-
EGFR protein, human
-
ErbB Receptors